Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP: NHS 'must urgently offer' HIV breakthrough nationwide as study shows infections cut 25% in a year

'Unacceptable' that PrEP provision in England is capped when there are no limits in other UK nations, National Aids Trust chief says

Published
22 hours ago
From
The Independent
Malawi: Sex workers demand access to PrEP

Ministry of Health officials in Malawi announced that the government is yet to rollout guidelines on PrEP. But Health Rights advocates have expressed worry over the delay in adopting new HIV prevention technologies like these.

Published
23 hours ago
From
Key Correspondents
CDC Encourages Health Care Providers to “Prescribe HIV Prevention”

The federal initiative aims to help clinicians and their patients understand and access PrEP and PEP.

Published
23 hours ago
From
Poz
Truvada and the truth: is HIV prevention propelling the STI epidemic?

In the MSM community, a rapidly expanding STI epidemic is fueling questions about whether the steadily rising number of people who start Truvada for HIV prevention subsequently change their sexual behavior in ways that increase their risk of contracting chlamydia, gonorrhea, syphilis and, in rarer cases, hepatitis C.

Published
21 October 2018
From
The Guardian
Groundbreaking Australian HIV trial should be replicated, researchers say

High-income countries with people at high risk of HIV should replicate a groundbreaking trial in Australia, which has seen new infections fall by 25% in one year following the rapid rollout of free HIV medication, researchers say.

Published
19 October 2018
From
The Guardian
No Prevention, No End: AVAC Report 2018

In just about 24 months, the world will arrive at the deadline for the UNAIDS "Fast Track" goals for ending the epidemic. The primary fast-track goal for HIV prevention is reduction in new diagnoses from roughly 2,000,000 a year, to less than 500,000. There's no chance this goal will be achieved.

Published
18 October 2018
From
AVAC
A Blue Pill Is Stopping HIV, World-First Study Shows

An antiviral pill taken daily by thousands of men across Sydney and other parts of Australia led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.

Published
18 October 2018
From
Bloomberg
My PrEP Story: Will

As the IMPACT Trial hits its first anniversary, PrEPster co-founder Will Nutland says that the waiting needs to stop: full implementation of PrEP must become a priority.

Published
12 October 2018
From
Prepster
Study reveals racial differences in HIV prevention method use

Black women report higher levels of medical mistrust — hindering their access to an important HIV prevention medication — according to a new study published by researchers at the Yale School of Public Health and George Washington University.

Published
09 October 2018
From
Yale Daily News (blog)
HIV prevention drug PrEP to be evaluated for State funding

Health authorities have begun a formal process to evaluate the possibility of introducing a State-funded HIV prevention drug.

Published
08 October 2018
From
Irish Times
← First12345...116Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.